Introduction

Oncology Reports

1021-335X 1791-2431

D.A. Spandidos

10.3892/or.2017.6108

or-39-02-0851

Articles

Novel evidence that pituitary sex hormones regulate migration, adhesion, and proliferation of embryonic stem cells and teratocarcinoma cells

Sellers

Zachariah Payne

1 * Bujko

Kamila

1 * Schneider

Gabriela

1 Kucia

Magdalena

2 Ratajczak

Mariusz Z.

1 2

1Stem Cell Institute at James Graham Brown Cancer Center, University of Louisville, Louisville, KY 40202, USA 2Department of Regenerative Medicine, Medical University of Warsaw, 02-091 Warsaw, Poland

Correspondence to: Professor Mariusz Z. Ratajczak, Stem Cell Institute at James Graham Brown Cancer Center, University of Louisville, 500 South Floyd Street, Louisville, KY 40202, USA, E-mail: mzrata01@louisville.edu *

Contributed equally

022018

24112017

39 2 851 859 06072017 07112017

2018

The pituitary sex hormones (SexHs): follicle-stimulating hormone (FSH), luteinizing hormone (LH), and prolactin (PRL) regulate several functions crucial for reproduction, including oogenesis, spermatogenesis, and lactation. An important source of prolactin-like hormones, known as lactogens, is the placenta, and lactogens bind to the PRL receptor (PRLR) with high affinity and thereby mimic the actions of PRL. Recently, it has been demonstrated that pituitary SexHs were involved in metastatic lung cancer, certain sarcomas, and leukemia. In the present study we aimed to investigate whether FSH, LH, and PRL were able to stimulate stem cells involved in early development. To address this issue we employed a murine embryonic stem cell line (ES-D3) as well as two teratocarcinoma cell lines, P19 (murine) and NTera2 (human). We determined that all these cells expressed SexH receptors at the mRNA and protein levels and that stimulation of these receptors induced phosphorylation of p42/44 MAPK, p38 MAPK, and AKT. Moreover, ES-D3, P19, and NTera2 cells responded with increased migration and adhesion to physiological concentrations of pituitary SexHs. In view of these findings we proposed that maternal-derived pituitary SexHs regulate the biology of stem cells involved in early development.

FSH LH PRL embryonic stem cells teratocarcinoma chemotaxis

Introduction

It is well known that sex hormones (SexHs) regulate the growth and function of the reproductive organs and are responsible for the development of secondary sex characteristics. While peptide-based sex hormones, including follicle-stimulating hormone (FSH), luteinizing hormone (LH), and prolactin (PRL), are secreted by the pituitary gland, steroid SexHs, such as estrogens, androgens, and progesterone, are released from the ovaries or testes. Notably, an important source of SexHs during development is the placenta (1,2). In parallel, as previously postulated, maternally-derived SexHs may also affect the developing embryo (3,4).

Evidence has accumulated which revealed, that as potent mitogens, SexHs play an important role in the development and progression of cancers arising from tissues that are sensitive to SexH stimulation, such as the gonads, uterus, prostate, and breast (5–8). However, it has been recently demonstrated that both pituitary- and gonad-derived SexHs also play a role in the pathogenesis of other malignancies, such as lung cancer (9), rhabdomyosarcoma (10) and leukemia (11), and direct migration and adhesion of cells derived from these malignancies.

It has been previously postulated by us and other researchers that the most primitive stem cells residing in adult tissues share several characteristics with primordial germ cells (PGCs), which are precursors of gametes and most likely precursors of stem cells in other tissues (12–14). This tempting hypothesis suggests that in postnatal tissues there are stem cells endowed with embryonic/epiblast/germline potential. In fact, in adult tissues stem cells, now known as very small embryonic-like stem cells (VSELs), have been identified to fulfill some of these criteria (15,16). These small cells have been found to be involved in physiological tissue and organ rejuvenation, but it is hypothesized that in some situations they also give rise to malignancies (17).

The notion that a population of stem cells involved in early development resides in adult tissues may corroborate the 150-year-old ‘embryonic rest hypothesis’ of cancer development. In the middle of the XIX century, two German pathologists, Rudolf Virchow and Julius Cohnheim, proposed this intriguing hypothesis, in which cancer may develop from embryonic cell remnants that remain in the developing organs following embryogenesis (18,19). This hypothesis was popular among pathologists in the 19th and 20th centuries but later was largely abandoned. In fact, the morphology of most primitive tumors often mimics tissues in early development, and such tumors may express markers that are characteristic of embryonic, epiblast, and/or germline cells. Recently, we demonstrated that as postulated the most primitive stem cells residing in adult tissues, VSELs express functional SexH receptors (20–25).

To pursue this idea we investigated whether SexHs play a role in regulating the biology of the murine embryonic ES-D3 cell line as well as the murine P19 teratocarcinoma cell line and the human embryonal carcinoma NTera2 cell line. The results revealed that these cells derived in early development expressed SexH receptors at the mRNA and protein levels, and stimulation of these receptors induced phosphorylation of p42/44 MAPK, p38 MAPK, and AKT. Moreover, ES-D3, P19, and NTera2 cells responded with increased migration and adhesion to physiological concentrations of FSH, LH, and PRL. With these results in mind we proposed that pituitary SexHs regulate the biology of stem cells involved in early development.

Materials and methods <sec> <title>Cell lines

All cell lines were obtained from the American Type Culture Collection (ATCC; Manassas, VA, USA). The human multipotent embryonal carcinoma cell line NTera2 was cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS). The murine teratocarcinoma cell line P19 was cultured in minimum essential medium Eagle-α modification (MEM-α) with ribonucleosides and deoxyribonucleosides, supplemented with 7.5% bovine calf serum (BCS) and 2.5% FBS. The murine embryonic stem cell line ES-D3 was cultured in DMEM supplemented with 15% heat-inactivated FBS and 10 ng/ml leukemia inhibitory factor (LIF). All media contained 100 U/ml penicillin and 10 µg/ml streptomycin. All cells were cultured in a humidified atmosphere of 5% CO₂ at 37°C. The media was changed every 48 h, and the cells were split upon reaching confluency as previously described (26).

RT-PCR analysis

Total RNA was isolated using the RNeasy Mini kit, including treatment with DNase I (both from Qiagen Inc., Germantown, MD, USA). The purified mRNA (2,500 ng) was afterwards reverse-transcribed into cDNA using the First Strand cDNA Synthesis kit (Thermo Scientific, Waltham, MA, USA) according to the manufacturer's instructions and using a mixture of oligo(dT) and random hexamers. Amplification of the synthesized cDNA fragments was carried out using AmpliTaq Gold^® Polymerase (Applied Biosystems, Foster City, CA, USA) and sequence-specific primers (Table I) with 1 cycle of 8 min at 95°C; 2 cycles of 2 min at 95°C, 1 min at 60°C, and 1 min at 72°C; 40 cycles of 30 sec at 95°C, 1 min at 60°C, 1 min at 72°C; and 1 cycle of 10 min at 72°C.

Flow cytometric analysis

Cells were detached using non-enzymatic reagent CellStripper^® (Corning Costar, Lowell, MA, USA), followed by a 3-h incubation in appropriate medium with 0.5% BSA. Then, the cells were washed with phosphate-buffered saline (PBS), fixed by a 20-min incubation at RT in 3.7% paraformaldehyde, washed again, and incubated for 30 min in 2.5% BSA in PBS. The cells were then stained with primary rabbit polyclonal anti-FSHR antibody (1:50, cat. no. sc-13935) or rabbit polyclonal anti-LHR antibody (1:50, cat. no. sc-25828) (both from Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) for 1.5 h at 37°C. The cells were then washed and incubated with FITC-conjugated secondary anti-rabbit antibody (1:100, cat. no. 12154D; BD Biosciences, San Jose, CA, USA). Subsequently, the cells were analyzed using an LSR cell cytometer (BD Biosciences). Analysis of the data was performed using FlowJo 7.2.5 software (FlowJo, Ashland, OR, USA), and the cells incubated with secondary antibody only were used as controls (1:100, cat. no. 12154D; BD Biosciences).

Phosphorylation of intracellular pathway proteins

The P19 and ES-D3 cell lines were incubated overnight and the NTera2 cell line for 9 h in appropriate medium containing 0.5% BSA to render the cells quiescent. The cells were then stimulated with pituitary hormones (all from ProSpec-Tany TechnoGene Ltd., Ness-Ziona, Israel): FSH (10 U/ml), LH (10 U/ml), and PRL (0.5 µg/ml) at 37°C for 5 min, then lysed for 20 min on ice in RIPA lysis buffer (Santa Cruz Biotechnology Inc.) containing protease and phosphatase inhibitors (Sigma-Aldrich, St. Louis, MO, USA). The extracted proteins were separated on a 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gel and transferred to a polyvinylidene difluoride (PVDF) membrane. Phosphorylation of the serine/threonine kinase AKT (phospho-AKT473, cat. no. 9271, dilution 1:1,000) and p44/42 mitogen-activated kinase (phospho-p44/42 MAPK, cat. no. 9101, dilution 1:2,000) was detected by rabbit antibodies with HRP-conjugated goat anti-rabbit secondary antibodies (cat. no. 7074S, dilution 1:5,000). Phosphorylation of the p38 mitogen-activated kinase (phospho-p38 MAPK, cat. no. 9216, dilution 1:1,000) was detected by mouse antibody with HRP-conjugated goat anti-mouse secondary antibody (cat. no. 7076, dilution 1:5,000). Equal loading in the lanes was evaluated by stripping the blots and reprobing with anti-AKT (cat. no. 9272, dilution 1:1,000) and anti-p38 MAPK (cat. no. 9212, dilution 1:1,000) rabbit antibodies followed by incubation with HRP-conjugated goat anti-rabbit secondary antibody (cat. no. 7074S, dilution 1:5,000) or with anti-p42/44 MAPK mouse monoclonal antibody followed by incubation with HRP-conjugated goat anti-mouse secondary antibody (cat. no. 7076, dilution 1:5,000). All antibodies were purchased from Cell Signaling (Danvers, MA, USA). The membranes were developed with enhanced chemiluminescence (ECL) reagent (Amersham Life Sciences, Arlington Heights, IL, USA) and subsequently exposed to film (Hyperfilm; Amersham Life Sciences, Arlington Heights, IL, USA).

Chemotaxis

Chemotaxis assays were performed in a modified Boyden's chamber with 8-µm polycarbonate membrane inserts (Costar Transwell; Corning Costar) as previously described (24). Cell suspensions were quiescent for 0.5–2 h in medium with 0.2% BSA. Prior to experiments the inserts were covered with 1% gelatin in PBS for 1 h at 37°C. Immediately after gelatin removal, the cells were seeded into the upper chamber of an insert at a density of 8–12×10⁴ cells/100 µl. The lower chamber was filled with pre-warmed DMEM (for NTera2 and ES-D3) or MEM-α (for P19) containing test reagents. The medium supplemented with vehicle was used as a negative control. In some experiments, ES-D3 cells were pretreated with inhibitors UO126 (1 µM; Promega, Madison, WI, USA), MK2206 (1 µM; Selleckchem, Houston, TX, USA), SB203580 (10 µM; Tocris, Minneapolis, MN, USA) for 10 min and loaded to the upper chamber. For these experiments, inhibitors were also present in the lower chambers throughout the duration of the experiment. After 36 h, the inserts were removed from the Transwell supports. The cells that had not migrated were scraped off with a cotton swab from the upper membrane, and the cells that had migrated to the lower side of the membrane were fixed and stained with HEMA 3 (following the manufacurer's protocol; Fisher Scientific, Pittsburgh, PA, USA) and counted on the lower side of the membrane using an inverted microscope.

Adhesion assay to fibronectin

Plates (96-wells) were coated with fibronectin (10 µg/ml) overnight at 4°C and blocked with 0.5% BSA for 1 h before the experiment. The cells were made quiescent for 2 h with the appropriate medium (DMEM or MEM-α) containing 0.5% BSA, followed by incubation with pituitary hormones for 10 min. Subsequently, cell suspensions (2×10³ cells/100 µl) were added directly to the fibronectin-coated wells and incubated for 5 min at 37°C. Following incubation, non-adherent cells were removed, and fresh medium with BSA was added. The cells were incubated for an additional 10 min, washed twice, and the number of adherent cells counted using an inverted microscope was performed as previously described (27).

Cell proliferation

Cells were seeded at an initial density of 1×10⁴ cells/cm² (P19 and NTera2) or 0.5×10⁴ cells/cm² (ES-D3). The medium was changed after 24 h to new medium supplemented with 0.5% BSA with or without hormones. For a positive control, new medium supplemented with 10% FBS was employed. At 24, 48 and 72 h after the medium was changed, the cells were trypsinized, stained with Trypan blue, and counted using a Neubauer chamber.

Statistical analysis

Statistical analysis was performed using the t-test (for data having a normal distribution) or the Mann-Whitney test (for data not having a normal distribution), with P≤0.05 considered significant.

Results <sec> <title>Murine and human cell lines involved in early development express functional sex hormone (SexH) receptors

First, we employed RT-PCR to assess the expression of peptide- and steroid-based SexH receptors, and we determined that the analyzed cell lines expressed a majority of these receptors, including peptide-based SexH receptors (Fig. 1A). We additionally confirmed the presence of FSH and LH receptors on the surface of the analyzed cell lines by FACS (Fig. 1B) and found that their expression was detectable on the surface of ES-D3, P19, and NTera2 cells.

To address whether FSH, LH, and PRL receptors were functional, we employed signal transduction experiments to examine whether stimulation with peptide-based SexHs activated signaling pathways involved in cell migration and adhesion. As shown in Fig. 2, all of the SexHs studied induced p42/44 MAPK, p38 MAPK and AKT phosphorylation; however, the pattern of activation depended on the cell type. While ES-D3 responded robustly to stimulation by FSH, LH, and PRL by p42/44 MAPK and AKT stimulation, P19 and NTera2 cells exhibited a strong response to FSH and a weaker response to LH. Robust activation of p38 MAPK was observed in all cell lines in response to FSH, and in a less extent to LH and prolactin. The response of AKT to stimulation by pituitary SexHs was observed in ES-D3 and NTera2 cells after stimulation by FSH and LH and in P19 cells after exposure to FSH.

Peptide-based SexH receptors modulate the chemotactic responsiveness and adhesion of murine and human cell lines in the early developmental stage

To address whether SexHs modulated migration of the investigated murine and human cell lines, we employed the Transwell system, in which two chambers were separated with a porous membrane. The lower chamber was prefilled with warm medium supplemented with the studied SexHs, and the cells were seeded into the upper chamber. After 24 h the inserts were removed, and the cells that had migrated from the upper to the lower side of the membrane were stained and counted under a microscope. As shown in Fig. 3, all studied SexHs stimulated migration of ES-D3, P19, and NTera2 cells. Notably, all cell lines responded not only to supraphysiological concentrations of FSH and LH but also to lower concentrations detected in human plasma. By contrast, while ES-D3 cells responded to a steep gradient of PRL only (Fig. 3A), P19 and NTera2 cells were chemoattracted to a lower physiological dose of this hormone (Fig. 3B and C).

To address whether FSH-, LH-, and PRL-stimulated migration dependend on the activation of AKT, p42/44, and p38 MAPK signaling pathways, we assessed the migration of ES-D3 upon stimulation with LH, FSH and prolactin in the presence of the appropriate inhibitors. We determined that, while the response of ES-D3 cells to FSH stimulation was decreased only in the presence of AKT (MK2206) and p38 MAPK (SB203580) (Fig. 4A), their response to LH and prolactin was inhibited by MEK, AKT, and p38 MAPK inhibitors, UO126, MK2206, and SB203580, respectively (Fig. 4B and C).

We also analyzed whether pituitary SexHs increased adhesion of the cell lines investigated in our study and determined that stimulation of ES-D3, P19, and NTera2 cells with FSH, LH, and PRL induced adhesion of these cells to fibronectin (Fig. 5).

The effect of pituitary SexHs on the proliferation of murine and human cell lines early-developmental-stage

FSH, LH, and PRL are known to be potent mitogens for some types of cells. As shown in Figs. 6 and 7, we added SexHs at the indicated doses on day 0 and analyzed the number of cells 24, 48 and 72 h later. We observed that FSH slightly stimulated proliferation of ES-D3 (Fig. 6A) and NTera2 (Fig. 7) cells if added to medium containing 0.5% BSA. By contrast, no effect of LH or PRL was observed.

Discussion

The salient observation of this study is that established cell lines derived in early development, including the murine embryonic ES-D3, the murine teratocarcinoma P19, and the human embryonal carcinoma NTera2 cell lines, express functional SexH receptors. Thus, our results indicated that pituitary SexHs may affect the biology of murine and human stem cells during the earliest stages of embryogenesis. Moreover, placenta-derived PRL-like hormones (known as lactogens), which bind with high affinity to the PRL-receptor and thereby mimic the actions of PRL, may also be involved in this process (28).

Recently, it was demonstrated that pituitary SexHs were involved in metastatic lung cancer (9), certain sarcomas (10), and leukemia (11). In the present study we investigated whether FSH, LH, and PRL stimulated cells in the early developmental stage.

It is well known that pituitary SexHs affect development and regulate biological processes in gonadal, prostate, and breast tissue (5–8). We recently demonstrated that pituitary SexHs were also involved in regulating normal hematopoiesis (20,21), which supports their having direct pleiotropic effects on extra-gonadal tissues in the adult organism.

On the other hand, evidence has accumulated that pituitary SexHs are involved in gonadal, breast, and prostate malignancies (5–8). Recent evidence revealed as aforementioned that these hormones were also involved in the pathogenesis of lung cancer, pediatric sarcomas, and leukemia. In our current study we demonstrated for the first time that certain malignancies derived from cells involved in early development, such as murine P19 teratocarcinoma cells and human embryonal carcinoma NTera2 cells, were highly sensitive to pituitary SexH stimulation, even when employed at physiological concentrations in peripheral blood (29). Notably, the concentration of some SexHs, such as FSH, increase with advancing age as a result of age-dependent gonadal dysfunction (30,31).

Our results are important for another reason. It has been proposed in the past that some cells from early embryonic development may continue to reside in adult tissues (18,19,32–34). This hypothesis was the basis for a theory proposed in the XIX century by Recamier (1829) (32), Remak (1854) (33), Virchow (1858) (18) and later elaborated by Durante (1874) (34) and Cohnheim (1875) (19) that some malignancies are derived from such embryonic remnants. This theory was known as the embryonic rest hypothesis for cancer development and was popular in older pathology textbooks (18,19,32–34).

The presence of certain populations of primitive stem cells in adult tissues that are endowed with the ability to differentiate into all three germ layers has been proposed by several researchers. Examples of such cells described in the literature include i) multipotent adult progenitor cells (MAPCs) (35); ii) marrow-isolated adult multilineage-inducible (MIAMI) cells (36); iii) multipotent adult stem cells (MASCs) (37); iv) elutriation-derived (Fr25/Lin⁻) stem cells (ELH SCs) (38); v) spore-like stem cells (39); vi) pluripotent Sca-1⁺CD45⁻c-kit⁻ cells (40); and vii) multilineage-differentiating stress-enduring stem cells (Muse SCs) (41). An interesting population of stem cells endowed with pan-germ-layer differentiation potential has been identified by our team and confirmed subsequently by several independent researchers as very small embryonic-like stem cells (VSELs) (15,20–25,42–45). The similarity of all the stem cells listed above with respect to the expression of certain genes involved in early development suggests that they are related to each other, that they represent similar and overlapping populations of primitive SCs that reside in adult tissues, and that they are endowed with broader pan-germ-layer differentiation potential (46). These stem cell types were identified by employing different direct or indirect isolation protocols and identification techniques, and based on this they were given different names. We propose that, due to their primitive embryonic morphology and gene expression for embryonic and primordial germline markers, VSELs are at the top of the hierarchy of these cells, which is consistent with an old concept that germline stem cells are not only developmental in origin but also remain as a ‘skeleton’ of the stem cell compartment in adult tissues (46).

We demonstrated in the past that VSELs express several receptors for SexHs, and our results reported in this study support the finding that the most primitive stem cells originating during development are responsive to SexHs (20–25). Since the pituitary gland develops later in embryogenesis, several of these hormones are derived from maternal blood, and in fact the potential effects of pituitary and placental SexHs on the developing embryo are not very well addressed in literature.

Cell migration and adhesion are regulated by different factors, such as chemokines, growth factors, cytokines, bioactive lipids, and extracellular nucleotides (27,47–49). However our recent and already published results indicate that pituitary SexHs also play an important role, which has been observed in both normal and malignant cells (9–11,20–23). While pituitary SexHs were found to increase the proliferation of several tumors, we observed only a very weak effect of FSH on proliferation of ES-D3 and NTera-2 cells. The role of pituitary SexHs, in particular, in the pathogenesis of cancer requires further study, since, as aforementioned, the concentration of FSH in peripheral blood increases with age due to gonadal dysfunction (30,31).

In conclusion, we found that pituitary SexHs stimulated migration and adhesion of established immortalized cell lines derived from the inner cell mass of the blastocyst (ES-D3) as well as from early germline tumors (P19, NTera2). Therefore, pituitary SexHs derived from maternal blood may affect the early stages of embryonic development. Moreover, lactogens, which can bind with high affinity to the PRL-receptor and thereby mimic the actions PRL, may also be involved in this process (28). This possibility, however, requires further study.

Our observations also shed new light on the potential role of these hormones in early embryonic development and cancerogenesis, particularly in light of the embryonic rest hypothesis proposed by Virchow and Connheim (18,19). However, we are aware that this concept also warrants more experimental investigation.

Acknowledgements

This study was supported by NIH grants 2R01 DK074720 and R01HL112788, the Stella and Henry Endowment, and NCN grant: OPUS 2016/21/B/NZ4/00201 by the National Science Center in Poland to MK.

References 1

Costa

The endocrine function of human placenta: An overview

Reprod Biomed Online3214432016

10.1016/j.rbmo.2015.10.005

26615903

Pepe

Albrecht

Actions of placental and fetal adrenal steroid hormones in primate pregnancy

Endocr Rev166086481995

10.1210/er.16.5.608

8529574

Whitaker-Azmitia

Lobel

Moyer

Low maternal progesterone may contribute to both obstetrical complications and autism

Med Hypotheses823133182014

10.1016/j.mehy.2013.12.018

24485701

Gürbüz

Yalti

Ozden

Ficicioglu

High basal estradiol level and FSH/LH ratio in unexplained recurrent pregnancy loss

Arch Gynecol Obstet27037392004

10.1007/s00404-003-0490-0

12756582

van Kruchten

van der Marel

de Munck

Hollema

Arts

Timmer-Bosscha

de Vries

Hospers

Reyners

Hormone receptors as a marker of poor survival in epithelial ovarian cancer

Gynecol Oncol1386346392015

10.1016/j.ygyno.2015.06.032

26115976

Lønning

Poor-prognosis estrogen receptor-positive disease: Present and future clinical solutions

Ther Adv Med Oncol41271372012

10.1177/1758834012439338

22590486

3349075

García-Cruz

Piqueras

Huguet

Peri

Izquierdo

Musquera

Franco

Alvarez-Vijande

Ribal

Alcaraz

Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment

BJU Int110E541E5462012

10.1111/j.1464-410X.2012.11232.x

22584031

Bose

Ellis

Prognostic and predictive biomarkers of endocrine responsiveness for estrogen receptor positive breast cancer

Adv Exp Med Biol8821251542016

10.1007/978-3-319-22909-6_5

26987533

Abdelbaset-Ismail

Pedziwiatr

Schneider

Niklinski

Charkiewicz

Moniuszko

Kucia

Ratajczak

Pituitary sex hormones enhance the pro metastatic potential of human lung cancer cells by downregulating the intracellular expression of heme oxygenase 1

Int J Oncol503173282017

10.3892/ijo.2016.3787

27922667

Poniewierska-Baran

Schneider

Sun

Abdelbaset-Ismail

Barr

Ratajczak

Human rhabdomyosarcoma cells express functional pituitary and gonadal sex hormone receptors: Therapeutic implications

Int J Oncol48181518242016

10.3892/ijo.2016.3439

26983595

4809652

Abdelbaset-Ismail

Borkowska

Janowska-Wieczorek

Tonn

Rodriguez

Moniuszko

Bolkun

Koloczko

Eljaszewicz

Ratajczak

Novel evidence that pituitary gonadotropins directly stimulate human leukemic cells-studies of myeloid cell lines and primary patient AML and CML cells

Oncotarget7303330462016

10.18632/oncotarget.6698

26701888

Donovan

Gearhart

The end of the beginning for pluripotent stem cells

Nature41492972001

10.1038/35102154

11689953

Otte

Wruck

Adjaye

New insights into human primordial germ cells and early embryonic development from single-cell analysis

FEBS Lett591222622402017

10.1002/1873-3468.12716

28627120

Aflatoonian

Moore

Germ cells from mouse and human embryonic stem cells

Reproduction1326997072006

10.1530/REP-06-0022

17071771

Kucia

Halasa

Wysoczynski

Baskiewicz-Masiuk

Moldenhawer

Zuba-Surma

Czajka

Wojakowski

Machalinski

Ratajczak

Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human cord blood: Preliminary report

Leukemia212973032007

10.1038/sj.leu.2404470

17136117

Ratajczak

Shin

Liu

Marlicz

Tarnowski

Ratajczak

Kucia

Epiblast/germ line hypothesis of cancer development revisited: Lesson from the presence of Oct-4+ cells in adult tissues

Stem Cell Rev63073162010

10.1007/s12015-010-9143-4

20309650

2888917

Ratajczak

Schneider

Sellers

Kucia

Kakar

The embryonic rest hypothesis of cancer development - an old XIX century theory revisited

J Cancer Stem Cell Res2e10012014

Virchow

Editorial Archive fuer pathologische

Anatomie und Physiologie fuer klinische Medizin823541855 (In German)

Conheim

Congenitales, quergestreiftes muskelsarkon der nireren

Virchows Arch6564691875 (In German)

10.1007/BF01978936

Mierzejewska

Borkowska

Suszynska

Poniewierska-Baran

Maj

Pedziwiatr

Adamiak

Abdel-Latif

Kakar

Hematopoietic stem/progenitor cells express several functional sex hormone receptors-novel evidence for a potential developmental link between hematopoiesis and primordial germ cells

Stem Cells Dev249279372015

10.1089/scd.2014.0546

25607657

4390002

Abdelbaset-Ismail

Suszynska

Borkowska

Adamiak

Ratajczak

Kucia

Ratajczak

Human haematopoietic stem/progenitor cells express several functional sex hormone receptors

J Cell Mol Med201341462016

10.1111/jcmm.12712

26515267

Patel

Bhartiya

Testicular stem cells express follicle-stimulating hormone receptors and are directly modulated by FSH

Reprod Sci23149315082016

10.1177/1933719116643593

27189070

Patel

Bhartiya

Parte

Gunjal

Yedurkar

Bhatt

Follicle stimulating hormone modulates ovarian stem cells through alternately spliced receptor variant FSH-R3

J Ovarian Res6522013

10.1186/1757-2215-6-52

23870332

3728228

Shaikh

Anand

Kapoor

Ganguly

Bhartiya

Mouse bone marrow VSELs exhibit differentiation into three embryonic germ lineages and germ & hematopoietic cells in culture

Stem Cell Rev132022162017

10.1007/s12015-016-9714-0

28070859

Ratajczak

Bartke

Darzynkiewicz

Prolonged growth hormone/insulin/insulin-like growth factor nutrient response signaling pathway as a silent killer of stem cells and a culprit in aging

Stem Cell Rev134434532017

10.1007/s12015-017-9728-2

28229284

5493720

Sellers

Schneider

Bujko

Suszynska

Pedziwiatr

Do cancer cell lines have fixed or fluctuating stem cell phenotypes? - studies with the NTera2 cell line

Stem Cell Rev136036102017

10.1007/s12015-017-9743-3

28624968

Schneider

Glaser

Lameu

Abdelbaset-Ismail

Sellers

Moniuszko

Ulrich

Ratajczak

Extracellular nucleotides as novel, underappreciated pro-metastatic factors that stimulate purinergic signaling in human lung cancer cells

Mol Cancer142012015

10.1186/s12943-015-0469-z

26597723

4657356

Gertler

Bignon

Staten

Sakal

Tchelet

Krivi

Djiane

Proceedings of the Society for Experimental Biology and Medicine: Interaction of lactogenic hormones with the soluble extracellular domain of prolactin receptors

Proc Soc Exp Biol Med206273279

1994

10.3181/00379727-206-43758

8016164

Fischbach

Dunning

A Manual of Laboratory and Diagnostic Tests9th

Wolters Kluwer Health/Lippincott Williams & Wilkins

Philadelphia

2014

Araujo

Wittert

Endocrinology of the aging male

Best Pract Res Clin Endocrinol Metab253033192011

10.1016/j.beem.2010.11.004

21397200

3073592

Limpaphayom

Taechakraichana

Kittinunvorakoon

Serum estradiol and gonadotropins level in postmenopausal women with or without hormone replacement

J Med Assoc Thai801471521997

9175381

Androutsos

Karamanou

Stamboulis

Tsoucalas

Kousoulis

Mandelenaki

Joseph-Claude-Anthelme Récamier (1774–1852): Forerunner in surgical oncology

J BUON165725762011

22006773

Remak

Ein beitrag zur entwickelungsgeschichte der krebshaften geschwulste Deut Klin6701741854(In German)

Durante

Arch

Memori ed Osservazioni di Chirugia Practica112172261874 (In Italian)

Jiang

Jahagirdar

Reinhardt

Schwartz

Keene

Ortiz-Gonzalez

Reyes

Lenvik

Lund

Blackstad

Pluripotency of mesenchymal stem cells derived from adult marrow

Nature41841492002

10.1038/nature00870

12077603

D'Ippolito

Diabira

Howard

Menei

Roos

Schiller

Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential

J Cell Sci117297129812004

10.1242/jcs.01103

15173316

Beltrami

Cesselli

Bergamin

Marcon

Rigo

Puppato

D'Aurizio

Verardo

Piazza

Pignatelli

Multipotent cells can be generated in vitro from several adult human organs (heart, liver, and bone marrow)

Blood110343834462007

10.1182/blood-2006-11-055566

17525288

Goldenberg-Cohen

Avraham-Lubin

Sadikov

Goldstein

Askenasy

Primitive stem cells derived from bone marrow express glial and neuronal markers and support revascularization in injured retina exposed to ischemic and mechanical damage

Stem Cells Dev21148815002012

10.1089/scd.2011.0366

21905921

Vacanti

Roy

Cortiella

Bonassar

Vacanti

Identification and initial characterization of spore-like cells in adult mammals

J Cell Biochem804554602001

10.1002/1097-4644(20010301)80:3<455::AID-JCB180>3.0.CO;2-Z

11135375

Howell

Lee

Morrison

Zhong

Yoder

Srour

Pluripotent stem cells identified in multiple murine tissues

Ann NY Acad Sci9961581732003

10.1111/j.1749-6632.2003.tb03244.x

12799294

Wakao

Kitada

Kuroda

Shigemoto

Matsuse

Akashi

Tanimura

Tsuchiyama

Kikuchi

Goda

Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts

Proc Natl Acad Sci USA10898759880

2011

10.1073/pnas.1100816108

21628574

3116385

Guerin

Rossi

Saubamea

Cras

Mignon

Silvestre

Smadja

Human very small embryonic-like cells support vascular maturation and therapeutic revascularization induced by endothelial progenitor cells

Stem Cell Rev135525602017

10.1007/s12015-017-9731-7

28303468

Golipoor

Mehraein

Zafari

Alizadeh

Ababzadeh

Baazm

Migration of bone marrow-derived very small embryonic-like stem cells toward an injured spinal cord

Cell J176396472016

26862523

4746414

Bhartiya

Shaikh

Anand

Patel

Kapoor

Sriraman

Parte

Unni

Endogenous, very small embryonic-like stem cells: Critical review, therapeutic potential and a look ahead

Hum Reprod Update2341762016

10.1093/humupd/dmw030

27614362

Kassmer

Jin

Zhang

Bruscia

Heydari

Lee

Kim

Kassmer

Krause

Very small embryonic-like stem cells from the murine bone marrow differentiate into epithelial cells of the lung

Stem Cells31275927662013

10.1002/stem.1413

23681901

4536826

Ratajczak

Suszynska

Miller

Kucia

Shin

A novel view of the adult stem cell compartment from the perspective of a quiescent population of very small embryonic-like stem cells

Circ Res1201661782017

10.1161/CIRCRESAHA.116.309362

28057792

Majka

Drukala

Lesko

Wysoczynski

Jenson

Ratajczak

SDF-1 alone and in co-operation with HGF regulates biology of human cervical carcinoma cells

Folia Histochem Cytobiol441551642006

16977794

Schneider

Sellers

Bujko

Kakar

Kucia

Ratajczak

Novel pleiotropic effects of bioactive phospholipids in human lung cancer metastasis

Oncotarget858247582632017

28938552

5601648

Schneider

Bryndza

Poniewierska-Baran

Serwin

Suszynska

Sellers

Merchant

Kaliappan

Ratajczak

Kucia

Evidence that vitronectin is a potent migration-enhancing factor for cancer cells chaperoned by fibrinogen: A novel view of the metastasis of cancer cells to low-fibrinogen lymphatics and body cavities

Oncotarget769829698432016

27634880

5342518

Figure 1.

Murine and human early-developmental-stage cell lines express several sex hormone receptors. (A) RT-PCR results for expression of LHR, FSHR, PRLR, ERα, ERβ, ProgR, and AR in the murine stem cell line ES-D3, the teratocarcinoma cell line P19, and the human embryonal carcinoma cell line NTera2. cDNA from murine ovaries and from the human ovarian cancer cell line A2780 were used as controls. (B) Flow cytometric analysis of FSHR and LHR expression in the ES-D3, P19, and NTera2 cell lines. Representative results from two independent experiments are shown. LHR, luteinizing hormone receptor; FSHR, follicle stimulating hormone receptor; PRLR, prolactin receptor; ERα, estrogen α receptor; ERβ, estrogen β receptor; ProgR, progesterone receptor; AR, androgen receptor.

Figure 2.

Pituitary sex hormone receptors are functional in murine and human cell lines in the early developmental stage. Western blot analysis of p42/44 MAPK, p38 MAPK and AKT phosphorylation (p-p42/44 MAPK, p-p38 MAPK and p-AKT) upon FSH, LH, and PRL stimulation of the ES-D3, P19, and NTera2 cell lines. Representative results from two independent experiments are shown.

Figure 3.

Pituitary sex hormones stimulate the migration of murine and human cell lines in the early developmental stage. The effect of the pituitary hormone on the migration of (A) ES-D3, (B) P19, and (C) NTera2 cells. The migration of cells across Transwell membranes in response to pituitary hormones is presented graphically. Results from at least three experiments are shown, with *P≤0.5. Representative images of stained membranes are shown beneath the graphs.

Figure 4.

The pituitary sex hormone-stimulated migration of ES-D3 cells depends on the activation of AKT, p42/44 MAPK and p38. Pretreatment of ES-D3 cells with AKT (MK2206), p42/44 MAPK (U0136) and p38 MAPK (SB203580) inhibitors affected their migration upon stimulation with (A) FSH, (B) LH and (C) prolactin.

Figure 5.

Pituitary sex hormones stimulate adhesion of murine and human cell lines in the early developmental stage. The effect of pituitary hormones on adhesion of ES-D3, P19, and NTera2 cells to fibronectin. Results from two experiments are shown with *P≤0.5.

Figure 6.

FSH stimulates proliferation of murine ES-D3, but not P19 cells. The effect of pituitary hormone on the proliferation of (A) ES-D3 and (B) P19 cells. In the upper line graphs, the values are the percentage of cells on day 0. In the lower bar graphs, the values are normalized to the negative control, which represents 100% of cells on a particular day. For each cell line, the experiment was repeated twice in triplicate with similar results.

Figure 7.

FSH stimulates proliferation of human Ntera2 cell line. The effect of pituitary sex hormones on the proliferation of NTera2 cells. In the upper line graphs, the values are the percentage of cells on day 0. In the lower bar graphs, the values are normalized to the negative control, which represents 100% of cells on a particular day. For each cell line, the experiment was repeated twice in triplicate with similar results.

Table I.

List of primers used in this study.

	Murine primers

	Forward	Reverse
FSHR	TCAACGGAACCCAGCTAGATG	GTCTAAAACGACTGGCCCAGAG
LHR	ATCTGTAACACAGGCATCCGG	CGTTCCCTGGTATGGTGGTTAT
PRLR	TGCTTGCTGGGAAGTACGG	GGTGACGGAGATAGTTGGGG
ERα	GCCAAGGAGACTCGCTACTGTG	TGTCAATGGTGCATTGGTTTGT
ERβ	TACCCCTTGGCTACCGCAA	GCATCAGGAGGTTGGCCAG
ProgR	TCGACAGCTTGCATGATCTTG	CCAGTGTCCGGGATTGGAT
AR	GACTGCATGTACGCGTCGC	GGCGTAACCTCCCTTGAAAGAG
BMG	CATACGCCTGCAGAGTTAAGC	GATCACATGTCTCGATCCCAGTAG

	Human primers

	Forward	Reverse

FSHR	GCTTCTGAGATCTGTGGAGGTT	GGACAAACCTCAGTTCAATGGC
LHR	CCGGTCTCACTCGACTATCAC	TGAGGAGGTTGTCAAAGGCA
PRLR	CTGGGCTTTCTGCCTTACTCA	TTCTTTAGTTTTGCCAGGGAGCA
ERα	AGGTGCCCTACTACCTGGAG	CGGTCTTTTCGTATCCCACCT
ERβ	TTTTTGGACACCCACTCCCC	CACCTGTTGAGGAAAGCGAG
ProgR	CGGACACCTTGCCTGAAGTT	CGGACACCTTGCCTGAAGTT
AR	CGACTTCACCGCACCTGATG	CTTCTGTTTCCCTTCAGCGG
β-actin	GGATGCAGAAGGAGATCACTG	GGATGCAGAAGGAGATCACTG

FSHR, follicle-stimulating hormone receptor; LHR, luteinizing hormone/choriogonadotropin receptor; PRL, prolactin receptor; ERα, estrogen receptor α; ERβ, estrogen receptor β; ProgR, progesterone receptor; AR, androgen receptor; BMG, β-2 microglobulin.